Nitesh Kumar Poddar

Dr. Nitesh Kumar Poddar


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
PSPallavi Sharma
Pallavi Sharma
ATArti Tyagi
Arti Tyagi
PBPravin Bhansali
Pravin Bhansali
SPShubhra Pareek
Shubhra Pareek
VSVineeta Singh
Vineeta Singh
NPNitesh Kumar Poddar
Nitesh Kumar Poddar

10 January 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ZMZeba Mueed
Zeba Mueed
PTPallavi Tandon
Pallavi Tandon
SMSanjeev Kumar Maurya
Sanjeev Kumar Maurya
RDRavi Deval
Ravi Deval
Mohammad KamalMohammad Kamal
Mohammad Kamal
NPNitesh Kumar Poddar
Nitesh Kumar Poddar
The hyperphosphorylation of tau protein and the overexpression of mTOR are considered to be the driving force behind Aβ plaques and Neurofibrillay Tangles (NFT's), hallmarks of Alzheimer's disease (AD). It is now evident that miscellaneous diseases such as Diabetes, Autoimmune diseases, Cancer, etc. are correlated with AD. Therefore, we reviewed the literature on the causes of AD and investigated the association of tau and mTOR with other diseases. We have discussed the role of insulin deficiency in diabetes, activated microglial cells, and dysfunction of blood-brain barrier (BBB) in Autoimmune diseases, Presenilin 1 in skin cancer, increased reactive species in mitochondrial dysfunction and deregulated Cyclins/CDKs in promoting AD pathogenesis. We have also discussed the possible therapeutics for AD such as GSK3 inactivation therapy, Rechaperoning therapy, Immunotherapy, Hormonal therapy, Metal chelators, Cell cycle therapy, γ-secretase modulators, and Cholinesterase and BACE 1-inhibitors which are thought to serve a major role in combating pathological changes coupled with AD. Recent research about the relationship between mTOR and aging and hepatic Aβ degradation offers possible targets to effectively target AD. Future prospects of AD aims at developing novel drugs and modulators that can potentially improve cell to cell signaling, prevent Aβ plaques formation, promote better release of neurotransmitters and prevent hyperphosphorylation of tau.

1 January 2011 in Life Sciences
Verified
Journal Article
Closed access
LSLaishram R. Singh
Laishram R. Singh
NPNitesh Kumar Poddar
Nitesh Kumar Poddar
TDTanveer Ali Dar
Tanveer Ali Dar
RKRaj Kumar
Raj Kumar
Faizan AhmadFaizan Ahmad
Faizan Ahmad

1 December 2008 in Biophysical Chemistry
Verified
Journal Article
Closed access
NPNitesh Kumar Poddar
Nitesh Kumar Poddar
ZAZ.A. Ansari
Z.A. Ansari
RSR.K. Brojen Singh
R.K. Brojen Singh
AMA.A. Moosavi-Movahedi
A.A. Moosavi-Movahedi
Faizan AhmadFaizan Ahmad
Faizan Ahmad

26 August 2022 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
AIAshal Ilyas
Ashal Ilyas
YWYasanandana Supunsiri Wijayasinghe
Yasanandana Supunsiri Wijayasinghe
IKIlyas Khan
Ilyas Khan
NSNourhan M. El Samaloty
Nourhan M. El Samaloty
Mohd AdnanMohd Adnan
Mohd Adnan
SKShahanavaj Khan
Shahanavaj Khan
Osmolytes are naturally occurring small molecular weight organic molecules, which are accumulated in large amounts in all life forms to maintain the stability of cellular proteins and hence preserve their functions during adverse environmental conditions. Trimethylamine N-oxide (TMAO) and N,N,N-trimethylglycine (betaine) are methylamine osmolytes that have been extensively studied for their diverse roles in humans and have demonstrated opposing relations with human health. These osmolytes are obtained from food and synthesized endogenously using dietary constituents like choline and carnitine. Especially, gut microbiota plays a vital role in TMAO synthesis and contributes significantly to plasma TMAO levels. The elevated plasma TMAO has been reported to be correlated with the pathogenesis of numerous human diseases, including cardiovascular disease, heart failure, kidney diseases, metabolic syndrome, etc.; Hence, TMAO has been recognized as a novel biomarker for the detection/prediction of several human diseases. In contrast, betaine acts as a methyl donor in one-carbon metabolism, maintains cellular S-adenosylmethionine levels, and protects the cells from the harmful effects of increased plasma homocysteine. Betaine also demonstrates antioxidant and anti-inflammatory activities and has a promising therapeutic value in several human diseases, including homocystinuria and fatty liver disease. The present review examines the multifarious functions of TMAO and betaine with possible molecular mechanisms towards a better understanding of their emerging and diverging functions with probable implications in the prevention, diagnosis, and treatment of human diseases.

25 September 2009 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
SJShazia Jamal
Shazia Jamal
NPNitesh Kumar Poddar
Nitesh Kumar Poddar
LSLaishram R. Singh
Laishram R. Singh
TDTanveer Ali Dar
Tanveer Ali Dar
VRVikas Rishi
Vikas Rishi
Faizan AhmadFaizan Ahmad
Faizan Ahmad
We report the effects of stabilizing osmolytes (low molecular mass organic compounds that raise the midpoint of thermal denaturation) on the stability and function of RNase‐A under physiological conditions (pH 6.0 and 25 °C). Measurements of Gibbs free energy change at 25 °C (ΔGD°) and kinetic parameters, Michaelis constant (Km) and catalytic constant (kcat) of the enzyme mediated hydrolysis of cytidine monophosphate, enabled us to classify stabilizing osmolytes into three different classes based on their effects on kinetic parameters and protein stability. (a) Polyhydric alcohols and amino acids and their derivatives do not have significant effects on ΔGD° and functional activity (Km and kcat). (b) Methylamines increase ΔGD° and kcat, but decrease Km. (c) Sugars increase ΔGD°, but decrease both Km and kcat. These findings suggest that, among the stabilizing osmolytes, (a) polyols, amino acids and amino acid derivatives are compatible solutes in terms of both stability and function, (b) methylamines are the best refolders (stabilizers), and (c) sugar osmolytes stabilize the protein, but they apparently do not yield functionally active folded molecules.